(Q42516895)

1 November 2017

Protein distribution of the orexin-2 receptor in the rat central nervous system (English)

1 reference

1 November 2017

Cluderay JE

1

1 reference

PubMed ID

11830288

1 November 2017

Harrison DC

series ordinal

2

1 reference

PubMed ID

11830288

1 November 2017

Hervieu GJ

series ordinal

3

1 reference

1 November 2017

1 March 2002

1 reference

1 November 2017

1 reference

1 November 2017

104

1 reference

1 November 2017

131-144

1 reference

1 November 2017

1-3

1 reference

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Distribution of orexin/hypocretin in the rat median eminence and pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Neurons containing hypocretin (orexin) project to multiple neuronal systems

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Distribution of orexin neurons in the adult rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

The lateral hypothalamic area revisited: ingestive behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Anti-obesity drugs: a critical review of current therapies and future opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

The hypocretin/orexin story.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Orexin A activates locus coeruleus cell firing and increases arousal in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Role of orexins in sleep and arousal mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Hypocretin (orexin) deficiency in human narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Narcolepsy: a key role for hypocretins (orexins)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Narcolepsy genes wake up the sleep field.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

A selective orexin-1 receptor antagonist reduces food consumption in male and female rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Distribution of orexin receptor mRNA in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

The use of quantitative RT-PCR to measure mRNA expression in a rat model of focal ischemia--caspase-3 as a case study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Specificity controls for immunocytochemical methods

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Hypocretin receptor protein and mRNA expression in the dorsolateral pons of rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Possible involvement of orexin in the stress reaction in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Effects of orexins on the hypothalamic-pituitary-adrenal system

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Pontine regulation of pelvic viscera: pharmacological target for pelvic visceral dysfunctions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Cellular Localization of Orexin Receptors in Human Pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

The neural network that regulates energy balance is responsive to glucocorticoids and insulin and also regulates HPA axis responsivity at a site proximal to CRF neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

Hypercortisolism and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

The effects of leptin on REM sleep and slow wave delta in rats are reversed by food deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900357-3

7 January 2021

10.1016/S0167-0115(01)00357-3

Identifiers

DOI

1 reference

1 November 2017

1 reference

PubMed ID

11830288